HemaSphere
(Aug 2023)
P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
- Xiaoyu Zhang,
- Jialin Wei,
- Yi He,
- Sizhou Feng,
- Mingzhe Han,
- Erlie Jiang
Affiliations
- Xiaoyu Zhang
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- Jialin Wei
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- Yi He
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- Sizhou Feng
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- Mingzhe Han
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- Erlie Jiang
- 1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin
- DOI
-
https://doi.org/10.1097/01.HS9.0000972120.95480.ad
- Journal volume & issue
-
Vol. 7
p.
e95480ad
WeChat QR code